BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27334081)

  • 1. [Tumour lysis syndrome in small-cell lung cancer].
    Boshuizen RC; Smit AA; Moons-Pasic A; Bresser P
    Ned Tijdschr Geneeskd; 2016; 160():A9823. PubMed ID: 27334081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous tumour lysis syndrome in small cell lung cancer: a rare phenomenon.
    Dhakal P; Rai MP; Thrasher M; Sharma M
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29898908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor lysis syndrome in small cell lung cancer: a case report and review of the literature.
    Jallad B; Hamdi T; Latta S; Alhosaini MN; Kheir F; Iroegbu N
    Onkologie; 2011; 34(3):129-31. PubMed ID: 21358219
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumour lysis syndrome in a patient with intravascular spread from a recurrent epithelial ovarian cancer.
    Camarata M; Davies R; Copley S; Blagden S
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23616333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor lysis syndrome in a nonsmall cell lung cancer.
    Noyes AM; Lonial K; Siegel RD
    Conn Med; 2014 Aug; 78(7):421-3. PubMed ID: 25195308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor lysis syndrome in extensive-stage small-cell lung cancer.
    Beriwal S; Singh S; Garcia-Young JA
    Am J Clin Oncol; 2002 Oct; 25(5):474-5. PubMed ID: 12393987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour Lysis Syndrome in children with haematological cancers: Experience at a tertiary care hospital in Karachi.
    Saeed F; Ali MS; Ashraf MS; Vadsaria K; Siddiqui DE
    J Pak Med Assoc; 2018 Nov; 68(11):1625-1630. PubMed ID: 30410139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor lysis syndrome in small cell lung cancer.
    Kallab AM; Jillella AP
    Med Oncol; 2001; 18(2):149-51. PubMed ID: 11778761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor lysis syndrome after induction chemotherapy in small-cell lung carcinoma.
    Hussein AM; Feun LG
    Am J Clin Oncol; 1990 Feb; 13(1):10-3. PubMed ID: 2154919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review.
    Vanhees SL; Paridaens R; Vansteenkiste JF
    Ann Oncol; 2000 Aug; 11(8):1061-5. PubMed ID: 11038047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour lysis syndrome in haematological malignancies.
    van der Hoven B; Thunnissen PL; Sizoo W
    Neth J Med; 1992 Feb; 40(1-2):31-5. PubMed ID: 1579184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Prevention of Tumour Lysis Syndrome in HER2-positive Breast Cancer: Case Report and Literature Review.
    Omori S; Shigechi T; Kawaguchi K; Ijichi H; Oki E; Yoshizumi T
    Anticancer Res; 2023 May; 43(5):2371-2377. PubMed ID: 37097695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carfilzomib-associated tumor lysis syndrome.
    Shely RN; Ratliff PD
    Pharmacotherapy; 2014 May; 34(5):e34-7. PubMed ID: 24390940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous tumour lysis syndrome in hepatocellular carcinoma presenting with hypocalcemic tetany: An unusual case and systematic literature review.
    Agarwala R; Batta A; Suryadevera V; Kumar V; Sharma V; Rana SS
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):e29-e31. PubMed ID: 27743982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute tumor lysis syndrome in a patient with mixed small cell and non-small cell tumor.
    Sewani HH; Rabatin JT
    Mayo Clin Proc; 2002 Jul; 77(7):722-8. PubMed ID: 12108612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature.
    Drakos P; Bar-Ziv J; Catane R
    Am J Clin Oncol; 1994 Dec; 17(6):502-5. PubMed ID: 7977169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature.
    Taira F; Horimoto Y; Saito M
    Breast Cancer; 2015 Nov; 22(6):664-8. PubMed ID: 23420376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration.
    Terpos E; Politou M; Rahemtulla A
    J Cancer Res Clin Oncol; 2004 Oct; 130(10):623-5. PubMed ID: 15449188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor lysis syndrome after bortezomib therapy for plasma cell leukemia.
    Jaskiewicz AD; Herrington JD; Wong L
    Pharmacotherapy; 2005 Dec; 25(12):1820-5. PubMed ID: 16305302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer.
    Spigel DR; Greco FA; Rubin MS; Shipley D; Thompson DS; Lubiner ET; Eakle JF; Quinn R; Burris HA; Hainsworth JD
    Lung Cancer; 2012 Aug; 77(2):359-64. PubMed ID: 22560921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.